Targeting Radiation-Resistant Prostate Cancer Stem Cells by B7-H3 CAR T CellsYida Zhang, Xinhui Wang, Gianpietro Dotti et al.|Molecular Cancer Therapeutics|2021Cited by 86
Phase II study of oral APL-1202 plus tislelizumab or tislelizumab alone as neoadjuvant therapy in patients with muscle-invasive bladder cancer (MIBC).Matthew D. Galsky, Xiaoliang Yuan, John P. Sfakianos et al.|Journal of Clinical Oncology|2025Cited by 1